| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |